SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
| Valuation | |
|---|---|
| Market Cap ($M) | 27.23 |
| Enterprise Value ($M) | 18.67 |
| Book Value ($M) | 36.90 |
| Book Value / Share | 4.00 |
| Price / Book | 0.74 |
| NCAV ($M) | 15.64 |
| NCAV / Share | 1.69 |
| Price / NCAV | 1.74 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -1.08 |
| Return on Assets (ROA) | -1.61 |
| Return on Equity (ROE) | -2.99 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 3.69 |
| Current Ratio | 3.69 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 32.54 |
| Assets | 53.80 |
| Liabilities | 16.89 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Radcliffe Capital Management, L.P. | 0.00 | -100.00 | |
| 13G/A | Commodore Capital Lp | 3.50 | -73.58 | |
| 13G | Rtw Investments, Lp | 9.99 | ||
| 13G | Biotechnology Value Fund L P | 9.99 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 12,099 | 54,556 | 22.18 | |
| 50,797 | 89,324 | 56.87 | |
| 15,655 | 46,013 | 34.02 | |
| 10,031 | 39,760 | 25.23 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| RNXT – RenovoRx, Inc. | RVPH – Reviva Pharmaceuticals Holdings, Inc. |
| RZLT – Rezolute, Inc. | SAVA – Cassava Sciences, Inc. |
| SBFM – Sunshine Biopharma, Inc. |
Financial data and stock pages provided by
Fintel.io